Key facts
- Field Medical’s last known valuation is $180.0M (Jun 2025).
- It has raised $75.0M across 2 recorded rounds; the latest was Early Stage VC ($35.0M) in Jun 2025.
- Notable investors include BioStar Capital, CUE Growth Partners, Cadence Healthcare Ventures.
- Field Medical has filed 2 Form Ds with the SEC, most recently Jul 2025 ($35.0M sold to 8 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Field Medical
Funding rounds
2 roundsAbout Field Medical
Developer of a pulsed electric technology designed to offer field ablation tools. The company's technology uses microbursts of energy to disrupt cells in the heart, which are delivered via catheter for the treatment of ventricular tachycardia, enabling medical professionals to improve on existing cardiac ablation treatments by improving efficacy and reducing unintended consequences.
- Sector
- Healthcare
- HQ
- Encinitas, CA, United States
- Founded
- 2022
- Employees
- 6
- Website
- fieldmedicalinc.com/
- Ownership
- Privately Held (backing)
Field Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Field Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Field Medical in its N-PORT filings yet. We sweep new filings monthly.